SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-139119
Filing Date
2020-12-23
Accepted
2020-12-23 16:19:30
Documents
1
Period of Report
2020-12-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2039296d1_4.html 4  
1 OWNERSHIP DOCUMENT tm2039296d1_4.xml 4 8959
  Complete submission text file 0001104659-20-139119.txt   10375
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 170 HARBOR WAY, 3RD FLOOR C/O AKERO THERAPEUTICS, INC. SOUTH SAN FRANCISCO CA 94080
Business Address
Cheng Andrew (Reporting) CIK: 0001778307 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 201412498